Compare Immunovant Inc. Common Stock (IMVT) vs TTM Technologies Inc. Common Stock (TTMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs TTM Technologies Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while TTM Technologies Inc. Common Stock trades at $120.8 (market cap $13.51B). The key difference: TTM Technologies Inc. Common Stock is far larger — about 2× Immunovant Inc. Common Stock's market cap, and TTM Technologies Inc. Common Stock is more actively traded (1,755,886 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and TTM Technologies Inc. Common Stock for 0 Days on average.
| IMVT | TTMI | |
|---|---|---|
Market Cap | $6.62B | $13.51B |
Volume | 1,131,364 | 1,755,886 |
Sector | Health | Technology |
52-Week High | $44.96 | $221.47 |
52-Week Low | $17.03 | $53.58 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $14.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About TTM Technologies Inc. Common Stock
TTM Technologies manufactures printed circuit boards, radio-frequency components, and electronics assemblies. Its products are used in aerospace, defense, automotive, data center, and communications equipment.
Read more on TTMI →
